Suppr超能文献

切口疝及其对细胞减灭术和腹腔内热化疗后健康相关生活质量的影响:一项全国前瞻性队列研究。

Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study.

机构信息

Department of Surgery, Colorectal Surgical Unit, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark.

出版信息

World J Surg Oncol. 2018 Apr 25;16(1):85. doi: 10.1186/s12957-018-1382-x.

Abstract

BACKGROUND

To evaluate the incidence of incisional hernia (IH) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) and its impact on health-related quality of life (HRQoL).

METHOD

From June 2006 until June 2016, 152 patients were followed after CRS + HIPEC at Aarhus University Hospital, a single national center. Patients were seen postoperatively in an outpatient clinic at 3, 6, 12, 18, 24, 36 48, and 60 months. Clinical examinations at these follow-up visits were used to evaluate IH events prospectively. The incidence of IH was estimated using competing risk analysis and is presented as the cumulative incidence proportion (CIP). We expected the incidence to be 15% at 12 months. HRQoL was assessed at 12 months by the Short Form (SF-36) questionnaire, which we used to compare patients with an IH to patients without an IH.

RESULTS

The median follow-up time was 16.6 months [range 0.9-62.0]. During this period, 14/152 (9.2%) patients developed an IH. The 1-year CIP was 5.9% [95% CI 2.9; 10.4] (n = 8), and the 2-year CIP was 9.2% [95% CI 5.3; 14.5] (n = 14). Patients with an IH were significantly older (67 years [range 48-72]) compared to patients without IH (60 years [range 24-75], p ≤ 0.01). The rate of postoperative complications between patients with and without IH was comparable, except that a greater proportion of patients with IH had a fascial dehiscence (21.4%) compared to patients without an IH (3.6%). Reponses to the SF-36 show that patients with an IH report lower HRQoL with regard to Role-physical (mean difference - 32.9 [95% CI - 60.6; - 5.3]) and Role-emotional (mean difference - 20.2 [95% CI - 43.4; 3.1]), meaning a reduction in work and daily activities due to their physical and psychological health. We found no general decrease in HRQoL.

CONCLUSION

CRS + HIPEC do not increase the risk of IH as measured within 12 months postoperatively, contrary to expectations. However, patients with an IH report a limitation in daily activities, which can best be explained by changes in physical and psychological health. A larger cohort from multiple centres is necessary to verify our findings.

摘要

背景

评估细胞减灭术和腹腔热灌注化疗(CRS + HIPEC)后切口疝(IH)的发生率及其对健康相关生活质量(HRQoL)的影响。

方法

从 2006 年 6 月至 2016 年 6 月,在奥胡斯大学医院(一家全国性的单一中心)对接受 CRS + HIPEC 的 152 例患者进行了随访。患者在术后门诊接受随访,时间分别为 3、6、12、18、24、36、48 和 60 个月。在这些随访中,临床检查前瞻性地评估 IH 事件。使用竞争风险分析估计 IH 的发生率,并以累积发生率比例(CIP)表示。我们预计 12 个月时的发生率为 15%。12 个月时使用简明健康调查问卷(SF-36)评估 HRQoL,并用该问卷比较 IH 患者与无 IH 患者。

结果

中位随访时间为 16.6 个月(0.9-62.0)。在此期间,14/152(9.2%)例患者发生 IH。1 年 CIP 为 5.9%[95%CI 2.9;10.4](n=8),2 年 CIP 为 9.2%[95%CI 5.3;14.5](n=14)。IH 患者明显比无 IH 患者年龄更大(67 岁[范围 48-72])(p≤0.01)。IH 患者和无 IH 患者术后并发症发生率相当,只是 IH 患者的筋膜裂开比例更高(21.4%),而无 IH 患者的筋膜裂开比例为 3.6%(p≤0.01)。SF-36 的反应表明,IH 患者的 HRQoL 在生理职能(平均差异-32.9[95%CI-60.6;-5.3])和情感职能(平均差异-20.2[95%CI-43.4;3.1])方面较低,这意味着由于身体和心理健康问题,工作和日常活动受限。我们没有发现 HRQoL 普遍下降。

结论

与预期相反,在术后 12 个月内,CRS + HIPEC 并不会增加 IH 的风险。然而,IH 患者报告日常活动受限,这最好用身体和心理健康的变化来解释。需要来自多个中心的更大队列来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55a/5918556/15b17c928862/12957_2018_1382_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验